Organic Letters
Letter
Gardner, S.; Ong, B. S. J. Am. Chem. Soc. 2005, 127, 614.
(c) Boudreault, P.-L. T.; Wakim, S.; Blouin, N.; Simard, M.; Tessier,
C.; Tao, Y.; Leclerc, M. J. Am. Chem. Soc. 2007, 129, 9125. (d) Wang,
C.; Dong, H.; Hu, W.; Liu, Y.; Zhu, D. Chem. Rev. 2011, 112, 2208.
(3) For reviews, see: (a) Driver, T. G. Org. Biomol. Chem. 2010, 8,
3831. (b) Stokes, B. J.; Driver, T. G. Eur. J. Org. Chem. 2011, 2011,
4071.
(4) cf. (a) Stokes, B. J.; Dong, H.; Leslie, B. E.; Pumphrey, A. L.;
Driver, T. G. J. Am. Chem. Soc. 2007, 129, 7500. (b) Shen, M.; Leslie,
B. E.; Driver, T. G. Angew. Chem., Int. Ed. 2008, 47, 5056. (c) Stokes,
B. J.; Richert, K. J.; Driver, T. G. J. Org. Chem. 2009, 74, 6442.
(d) Pumphrey, A. L.; Dong, H.; Driver, T. G. Angew. Chem., Int. Ed.
2012, 51, 5920.
54, 1606. (b) Naumov, M. I.; Nuchev, A. V.; Sitnikov, N. S.;
Malysheva, Y. B.; Shavyrin, A. S.; Beletskaya, I. P.; Gavryushin, A. E.;
Combes, S.; Fedorov, A. Y. Synthesis 2009, 2009, 1673.
(14) For the use of mercury or lead salts in the synthesis of
biologically active small molecules for pharmaceutical applications, see:
(a) Badham, N. F.; Chen, J.-H.; Cummings, P. G.; Dell’Orco, P. C.;
Diederich, A. M.; Eldridge, A. M.; Mendelson, W. L.; Mills, R. J.;
Novack, V. J.; Olsen, M. A.; Rustum, A. M.; Webb, K. S.; Yang, S. Org.
Process Res. Dev. 2002, 7, 101. (b) Kuethe, J. T.; Childers, K. G.;
Humphrey, G. R.; Journet, M.; Peng, Z. Org. Process Res. Dev. 2008, 12,
1201. (c) Wuts, P. G. M.; Ashford, S. W.; Conway, B.; Havens, J. L.;
Taylor, B.; Hritzko, B.; Xiang, Y.; Zakarias, P. S. Org. Process Res. Dev.
2009, 13, 331.
(15) The synthesis of 2-azidoarylboronic acid pinacolate esters 8 was
not optimized. Although the 2-aminoarylboronic acid pinacolate esters
precursors were synthesized for this study, all are commercially
available. See the Supporting Information for more details.
(16) Cf. (a) Hama, T.; Culkin, D. A.; Hartwig, J. F. J. Am. Chem. Soc.
2006, 128, 4976. (b) Ackermann, L.; Vicente, R.; Hofmann, N. Org.
(5) (a) Sun, K.; Sachwani, R.; Richert, K. J.; Driver, T. G. Org. Lett.
2009, 11, 3598. (b) Nguyen, Q.; Sun, K.; Driver, T. G. J. Am. Chem.
Soc. 2012, 134, 7262. (c) Nguyen, Q.; Nguyen, T.; Driver, T. G. J. Am.
Chem. Soc. 2013, 135, 620.
(6) For a discussion on the importance of step-economy in organic
synthesis, see: (a) Wender, P. A.; Verma, V. A.; Paxton, T. J.; Pillow, T.
H. Acc. Chem. Res. 2008, 41, 40. (b) Newhouse, T.; Baran, P. S.;
Hoffmann, R. W. Chem. Soc. Rev. 2009, 38, 3010.
Lett. 2009, 11, 4274. (c) Wurtz, S.; Lohre, C.; Frohlich, R.; Bergander,
̈
̈
K.; Glorius, F. J. Am. Chem. Soc. 2009, 131, 8344. (d) Taylor, A. M.;
Altman, R. A.; Buchwald, S. L. J. Am. Chem. Soc. 2009, 131, 9900.
(e) Zheng, B.; Jia, T.; Walsh, P. J. Org. Lett. 2013, 15, 4190.
(17) For leading reports of the use of the related oxindoles in α-
arylation processes, see: (a) Altman, R. A.; Hyde, A. M.; Huang, X.;
Buchwald, S. L. J. Am. Chem. Soc. 2008, 130, 9613. (b) Mai, C.-K.;
Sammons, M. F.; Sammakia, T. Org. Lett. 2010, 12, 2306. (c) Wu, L.;
Falivene, L.; Drinkel, E.; Grant, S.; Linden, A.; Cavallo, L.; Dorta, R.
Angew. Chem., Int. Ed. 2012, 51, 2870.
(7) For reviews, see: (a) Hartwig, J. F. Synlett 2006, 1283.
(b) Johansson, C. C. C.; Colacot, T. J. Angew. Chem., Int. Ed. 2010,
49, 676. (c) Mazet, C. Synlett 2012, 23, 1999.
(8) For recent transition-metal-catalyzed examples, see: (a) Bigot, A.;
Williamson, A. E.; Gaunt, M. J. J. Am. Chem. Soc. 2011, 133, 13778.
(b) Chernyak, N.; Buchwald, S. L. J. Am. Chem. Soc. 2012, 134, 12466.
(c) Donohoe, T. J.; Pilgrim, B. S.; Jones, G. R.; Bassuto, J. A. Proc.
Natl. Acad. Sci. U.S.A. 2012, 109, 11605. (d) Huang, Z.; Chen, Z.; Lim,
L. H.; Quang, G. C. P.; Hirao, H.; Zhou, J. S. Angew. Chem., Int. Ed.
2013, 52, 5807. (e) Alsabeh, P. G.; Stradiotto, M. Angew. Chem., Int.
Ed. 2013, 52, 7242.
(9) For α-arylation using anilide derivatives, see: (a) Xie, X.; Chen,
Y.; Ma, D. J. Am. Chem. Soc. 2006, 128, 16050. (b) Chen, Y.; Xie, X.;
Ma, D. J. Org. Chem. 2007, 72, 9329. (c) Chen, Y.; Wang, Y.; Sun, Z.;
Ma, D. Org. Lett. 2008, 10, 625. (d) Jiang, M.; Li, J.; Wang, F.; Zhao,
Y.; Zhao, F.; Dong, X.; Zhao, W. Org. Lett. 2012, 14, 1420. (e) Wang,
H.-Y.; Anderson, L. L. Org. Lett. 2013, 15, 3362. (f) Chan, W.-W.;
Zhou, Z.; Yu, W.-Y. Chem. Commun. 2013, 49, 8214.
(10) For leading reports on the α-arylation using I(III) reagents, see:
(a) Iwama, T.; Birman, V. B.; Kozmin, S. A.; Rawal, V. H. Org. Lett.
1999, 1, 673. (b) Aggarwal, V. K.; Olofsson, B. Angew. Chem., Int. Ed.
2005, 44, 5516. (c) Eastman, K.; Baran, P. S. Tetrahedron 2009, 65,
3149. (d) Allen, A. E.; MacMillan, D. W. C. J. Am. Chem. Soc. 2011,
133, 4260. (e) Review: Merritt, E. A.; Olofsson, B. Synthesis 2011,
2011, 517.
(18) (a) Staudinger, H.; Meyer, J. Helv. Chim. Acta 1919, 2, 635.
(b) Leffler, J. E.; Temple, R. D. J. Am. Chem. Soc. 1967, 89, 5235.
(c) Gololobov, Y. G.; Zhmurova, I. N.; Kasukhin, L. F. Tetrahedron
1981, 37, 437. (d) Gololobov, Y. G.; Kasukhin, L. F. Tetrahedron
1992, 48, 1353.
(19) Cf. (a) Nguyen, C. H.; Lavelle, F.; Riou, J.-F.; Bissery, M.-C.;
Huel, C.; Bisagni, E. Anti-Cancer Drug Des. 1992, 7, 235.
(b) Gillonneau, L.; Pierre,
́
A.; Charton, Y.; Guilbaud, N.; Kraus-
Berthier, L.; Leonce, S.; Michel, A.; Bisagni, E.; Atassi, G. J. Med. Chem.
́
1999, 42, 2191. (c) Hopkins, C. R. ACS Chem. Neurosci. 2010, 1, 587.
(20) cf. (a) Kobayashi, J.; Ishibashi, M. In The Alkaloids: Chemistry
and Pharmacology; Brossi, A., Cordell, G. A., Eds.; Academic Press: San
Diego, 1992; Vol. 41, pp 41−124. (b) Anthoni, U.; Christophersen,
C.; Nielson, P. H. In Alkaloids: Chemical & Biological Perspectives;
Pelletier, S. W., Ed.; Pergamon: Oxford, 1999; Vol. 13, pp 163−236.
(11) For leading examples of α-arylation using aryllead derivatives,
see: (a) Review: Elliott, G. I.; Konopelski, J. P. Tetrahedron 2001, 57,
5683. (b) Kozyrod, R. P.; Morgan, J.; Pinhey, J. T. Aust. J. Chem. 1985,
38, 1147. (c) Morgan, J.; Pinhey, J. T. J. Chem. Soc., Perkin Trans. 1
1990, 715. (d) Dyer, J.; King, A.; Keeling, S.; Moloney, M. G. J. Chem.
Soc., Perkin Trans. 1 2000, 2793. (e) Konopelski, J. P.; Lin, J.; Wenzel,
P. J.; Deng, H.; Elliott, G. I.; Gerstenberger, B. S. Org. Lett. 2002, 4,
4121. (f) Buston, J. E. H.; Moloney, M. G.; Parry, A. V. L; Wood, P.
Tetrahedron Lett. 2002, 43, 3407. (g) Xia, J.; Brown, L. E.; Konopelski,
J. P. J. Org. Chem. 2007, 72, 6885.
(12) For related noncatalyzed nucleophilic addition of enolates to
other aromatic derivatives, see: (a) Ooi, T.; Goto, R.; Maruoka, K. J.
Am. Chem. Soc. 2003, 125, 10494. (b) Koech, P. K.; Krische, M. J. J.
Am. Chem. Soc. 2004, 126, 5350. (c) Tambar, U. K.; Stoltz, B. M. J.
Am. Chem. Soc. 2005, 127, 5340. (d) Molinaro, C.; Mowat, J.;
Gosselin, F.; O’Shea, P. D.; Marcoux, J.-F.; Angelaud, R.; Davies, I. W.
J. Org. Chem. 2007, 72, 1856. (e) Huang, X.; Maulide, N. J. Am. Chem.
Soc. 2011, 133, 8510. (f) Mohanan, K.; Coquerel, Y.; Rodriguez, J. Org.
Lett. 2012, 14, 4686. (g) Xu, Q.-L.; Gao, H.; Yousufuddin, M.; Ess, D.
H.; Kurti, L. J. Am. Chem. Soc. 2013, 135, 14048.
̈
(13) For examples with more robust alkyl azides, see: (a) Ganina, O.
G.; Zamotaeva, S. G.; Nosarev, M. A.; Kosenkova, O. V.; Naumov, M.
I.; Shavyrin, A. S.; Finet, J.-P.; Fedorov, A. Y. Russ. Chem. Bull. 2005,
D
dx.doi.org/10.1021/ol5010615 | Org. Lett. XXXX, XXX, XXX−XXX